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ABSTRACT
ATF4 is a pro-oncogenic transcription factor whose
translation is activated by eIF2 phosphorylation
through delayed re-initiation involving two uORFs
in the mRNA leader. However, in yeast, the effect
of eIF2 phosphorylation can be mimicked by eIF5
overexpression, which turns eIF5 into translational
inhibitor, thereby promoting translation of GCN4, the
yeast ATF4 equivalent. Furthermore, regulatory pro-
tein termed eIF5-mimic protein (5MP) can bind eIF2
and inhibit general translation. Here, we show that
5MP1 overexpression in human cells leads to strong
formation of 5MP1:eIF2 complex, nearly comparable
to that of eIF5:eIF2 complex produced by eIF5 over-
expression. Overexpression of eIF5, 5MP1 and 5MP2,
the second human paralog, promotes ATF4 expres-
sion in certain types of human cells including fi-
brosarcoma. 5MP overexpression also induces ATF4
expression in Drosophila. The knockdown of 5MP1
in fibrosarcoma attenuates ATF4 expression and its
tumor formation on nude mice. Since 5MP2 is over-
produced in salivary mucoepidermoid carcinoma, we
propose that overexpression of eIF5 and 5MP in-
duces translation of ATF4 and potentially other genes
with uORFs in their mRNA leaders through delayed
re-initiation, thereby enhancing the survival of nor-
mal and cancer cells under stress conditions.
Being the major energy consuming process, mRNA
translation is tightly regulated (1). Many of the specific
mRNA targets of translational regulation include those en-
coding transcription factors, thereby allowing rapid cellu-
lar signaling involving global transcriptional changes. One
example is ATF4 mRNA, which encodes a pro-oncogenic
transcription factor (2) and whose translation is controlled
through special arrangement of two uORFs, uORF1 and
uORF2, found in its leader region. In contrast to the canon-
ical translation wherein the ribosome dissociates from
mRNAafter translation termination, the ribosome resumes
scanning after uORF1 translation. Under normal condi-
tions, the ribosome commits to re-initiate at uORF2, in-
hibiting downstream re-initiation at ATF4. However, when
certain stress signals come in, the ribosome pre-initiation
complex (PIC) does not assemble before the uORF2 start
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codon, resulting in the bypass of uORF2, but the PIC
assembles before the downstream start codon for ATF4,
thereby inducing ATF4 translation (3).
The choice of the re-initiation site at uORF2 or ATF4
start codon is ultimately determined by the availability of
the translation initiation factor eIF2, an essential PIC com-
ponent that delivers Met-tRNAiMet to the ribosome in a
GTP-dependent manner. In human, four eIF2 kinases
(eIF2K), PKR, PERK, GCN2 and HRI, phosphorylate
eIF2 at Ser 51 of its  subunit, thereby inhibiting its acti-
vation by guanine nucleotide exchange, and delaying PIC
assembly. Activation of PERK and GCN2 is known to in-
duceATF4 translation. However, in yeast, any perturbation
of other eIF activity or expression that results in inhibit-
ing eIF2 is shown to induce translation of GCN4, the yeast
equivalent of ATF4, whose mRNA leader also contains the
paired uORFs. For example, overexpression turns eIF5, a
canonical translation factor and binding partner of eIF2,
into the inhibitor of the initiator tRNA binding to the ri-
bosome, thereby mimicking the effect of eIF2 phosphory-
lation and inducing GCN4 (4). Furthermore, overexpres-
sion of the protein mimic and inhibitor for eIF5, termed
eIF5-mimic protein 1 (5MP1), was reported to induceATF4
translation in mouse embryonic fibroblasts with an eIF2
Ser 51-to-Ala mutation (5). This finding suggests the pres-
ence of alternative pathways for translational induction of
ATF4 through expression of a translational inhibitory pro-
tein. Because the overexpression of 5MP2/BZW1, the sec-
ond human paralogue of 5MP, appears to be responsible for
salivary mucoepidermoid carcinogenesis (6), the alternative
pathwaysmay be important for various biological processes
including tumorigenesis.
eIF5 interacts with both GTP- andGDP-bound forms of
eIF2. The eIF5 interaction with eIF2:GTP:Met-tRNAiMet
ternary complex occurs in the multifactor complex (MFC)
with eIF1 and eIF3, promoting Met-tRNAiMet recruitment
to 40S ribosomal subunits (7,8). The eIF5 interaction with
eIF2-GDP antagonizes the GDP/GTP exchange for the
latter, thereby inhibiting translation (4,9). The crucial role
eIF5 plays in controlling eIF2 function is not only estab-
lished in yeast, but is strongly supported in the entire Eu-
karya by the existence of its protein mimic, 5MP. 5MP does
not carry the GTPase activating function displayed by eIF5
(10), but possesses aW2-type CTD for eIF2 and eIF3 bind-
ing, similar to eIF5 (5). All eukaryotes except most proto-
zoans, yeasts and nematodes contain 5MP (11). The two
human copies, 5MP1 and 5MP2, are 70% identical to each
other and expressed in cultured mammalian cells at a level
stoichiometric to initiation factors (∼50–80% of eIF2 lev-
els) (12).
Although the interaction between 5MP and eIF2 and the
competition between 5MP and eIF5 for eIF2 have been
demonstrated in vitro (5,11), the interaction between 5MP
and eIF2 has not been demonstrated or even compared to
the interaction between eIF5 and eIF2 in human cells. Cu-
riously, the current proteomics databases do not list any in-
teraction between 5MP and eIF2 or between 5MP and any
other translation initiation factor.We generated plasmids to
overexpress human eIF5 and 5MP and compared their abil-
ities to bind eIF2 and other initiation factors and to induce
ATF4 in human cells. We find that human 5MP1 binds eIF2
and inducesATF4 similarly to eIF5. Furthermore, we show
that 5MP1 facilitates ATF4 expression in fibrosarcoma and
promotes its tumorigenesis. Our studies reveal a common
molecular basis for general translation inhibition by eIF5
and 5MPoverexpression, as well as for specific translational
induction of ATF4 through these stimuli.
MATERIALS AND METHODS
Cell culture and transfection
Human embryonic kidney (HEK) 293T (ATCC), HeLa sh-
PKR and shCtrl (kindly provided by Charles Samuel) (13),
human fibrosarcoma HT1080 (ATCC), and Drosophila
melanogaster S2 cells were grown and transfected and
HT1080 cell lines stably expressing sh 5MP1 or sh GFP
were generated and maintained, all as described in Sup-
plementary text. To express His6- and FLAG-tagged eIF5,
5MP1 and 5MP2, we cloned human cDNAs encoding
them under the EF1A promoter, generating pEF1A deriva-
tives (see Supplementary text for details). We also gen-
erated a pEF1A-heIF5 derivative carrying the Quad mu-
tation H305D/N306D/E347K/E348K, known to abolish
eIF5 binding to eIF2 and eIF1 (14).
Affinity purification and MS
Transfection of HEK293T with the pEF1A derivatives and
subsequent affinity purification were done as described pre-
viously (15), with modifications described in Supplemen-
tary file. Complex I and II fractions were subjected for
SDS-PAGE, followed by silver staining. Complex I pro-
teins ranging from 35 to 75 kDa were analyzed separately
in three gel pieces (Supplementary Table S1), while complex
II proteins in the whole lane were analyzed in 12 gel pieces
(Figures 2, 3 and Supplementary Figure S2). In-gel diges-
tion of protein bands and the MS analysis of the products
were performed as described (16), except that the analysis
of complex II fractions used C18 reverse-phase chromatog-
raphy (ADVANCE UHPLC, AMR) and a quadrapole
ion trap mass spectrometer (LTQ Orbitrap Velos Pro;
Thermo Fisher Scientific) with a Advanced Captive Spray
SOURCE mounted on a three-dimensional stage (AMR).
For complex I fractions, peptide fragments were applied to
a nanoflow high-performance liquid chromatography sys-
tem (Paradigm MS4; Michrom Bioresources, Auburn, CA,
USA) equipped with an L-column ODS (150 mm length ×
100 m ID, particle size of 3 m, CERI, Tokyo, Japan) and
analyzed with an LTQ-Orbitrap Discovery mass spectrom-
eter (ThermoFisher Scientific).
For semi-quantitative analysis of MS data, we used the
output files of Cut-off 30. We used emPAI as a proxy for
molar amount of proteins found in MS samples, as defined
as follows:
emPAI = 10
Nobserved
Nobservable − 1
where Nobserved (Nobd) is the number of peptides detected in
the experiment and Nobservable (Noble) is the number of pep-
tides theoretically detected per protein molecule (17). Al-
though Nobd/Noble values (PAI) are considered as the hall-
mark of molecular amounts detected in theMS experiment,
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comparison of this value and the known amount for 46
purified proteins indicated that the value correlated most
highly with logarithm of protein amount (r = 0.89) with
deviation factor (average ± S.D.) = 1.6 ± 0.5 (17). Thus,
emPAI (rather than Nobd/Noble = PAI) is the best proxy for
relative molecular amount of the protein present in the MS
sample. Assuming that eIF2, eIF2B, eIF3 and the riboso-
mal subunits bound to the FLAG-tagged 5MP1 or eIF5 as a
holo complex, the average total emPAI values computed for
individual protein subunits throughout each lane were em-
ployed as the relative molar amounts of each complex in the
complex II fractions and presented in Table 1. The signifi-
cance of protein association is judged by two criteria: (i) Ab-
sence of relevant peptides in the vector-transfected sample.
(ii) If peptides derived from a protein complex are present
in the vector-transfected sample, P-value is computed with
total emPAI values for measurement from each subunit of
the complex.
Luciferase reporter assay
Cells are transfected with a fixed ratio of a ATF4-firefly luc-
fierease plasmid and control Renilla luciferase plasmid, to-
gether with the eIF5 or 5MP expression plasmid, and sub-
jected for Dual GloR Luciferase Assay (Promega), as de-
scribed in detail in Supplementary text. For expression in
human cells, we used TK-ATF4-luc, its derivative carrying a
mutation altering the uORF1 or uORF2 start codon (3) or
fusing uORF2 in-frame with the luc gene (K.A., personal
collection) for the firefly construct and the control Renilla
luciferase plasmid (3). As a control for ATF4 induction,
cells were treated with 250 nM thapsigargin (Tg) for 16–20
h prior to the assay. For expression in insect cells, we used
D. melanogaster ATF4-luc plasmid p1696 for the firefly con-
struct and pAc5.1C-RLuc-V5His6 (18) for the Renilla con-
struct.
Fibrosarcoma experiments
Five homozygous male nude mice (NU/J, Jackson Labo-
ratory) were used. Animals were housed and cared within
the temperature-controlled the Division of Biology animal
facility at Kansas State University. Mice were maintained
in a 12:12 light:dark cycle and specific pathogen free fa-
cility (Helicobacter sp., mouse hepatitis virus, minute virus
of mice, mouse parvovirus, Sendai virus, murine norovirus,
Mycoplasma pulmonis, Theiler’s murine encephalomyeli-
tis virus and endo- and ecto- parasites). Food and water
were provided ad libitum. All animal experiments were per-
formed in accordance with NIH guidelines and with the ap-
proval of theKSU InstitutionalAnimal Care andUseCom-
mittee. Nude mice were subcutaneously injected with clone
5.3 (HT1080 sh5MP1) cells in their left flank, while all mice
received injections of negative control HT1080 in their right
flank. Cells (2 × 106) were mixed with equal volume of ma-
trigel and injected in 200 l volumes. When the total diam-
eters of tumors in both franks were ∼1.5 cm, mice were eu-
thanized and tumors were excised, photographed, weighed
and embedded in OCT freezing medium. OCT frozen sam-
ples are sectioned at 8m, stained by hematoxilyn and eosin
and subjected to pathological analysis.
Figure 1. Complex formation by eIF5 and 5MP1 in human cells. (A) Dou-
ble affinity purification of eIF5:eIF2 or 5MP1:eIF2 complexes (Complex
I). Top two gels show the immunoblots of the whole cell extracts (WCE)
with antibodies indicated to the right. In the third gel, complexes purified
from vector-treated (lane 1) or cells expressing His/FLAG-eIF5 (lane 2),
eIF5-Quad mutant (lane 3), or 5MP1 (lane 4) were stained by Coomassie
blue. Numbers beside each gel indicate the location of protein size stan-
dards in kDa. Numbers beside each band are the amounts of proteins
quantified by densitometric scanning in an arbitrary unit. Boxes on the
bottom indicate molar ratios of eIF2 to 5MP1 or eIF5. For eIF5, the ra-
tio was computed twice from eIF2/ and eIF2 bands and presented
on top and bottom, respectively. For 5MP1, this was computed from the
eIF2 band. Values in parenthesis are those obtained from another inde-
pendent experiment. (B andC) Single FLAG affinity purified complex of
eIF5 and 5MP1 (Complex II) contains eIF2 and eIF3. (B) Silver staining
and (C) immunoblots of 2.5% complexes II (lanes 1–4) and 8% complex
I fractions (lanes 5–8) from cells with indicated treatments are presented
with the position of protein size markers (in kDa). In (C), 0.3% of WCE
from vector-treated cells was analyzed together (lane 9). Detected proteins
are listed to the right of the blots. *, components of the PRMT5:MET50
complex, specifically found in the vector-treated sample (see Supplemen-
tary text for details).
Statistical analysis
We used Student’s t-test to obtain P-values. Bars in the
graphs denote SEM.
RESULTS
eIF5 and 5MP1 interact with eIF2 and eIF3 in human cells
To study 5MP interaction with initiation factors in human
cells and the effect of its overexpression on ATF4 expres-
sion, we cloned human cDNAs encoding 5MP1 under a
strong promoter (PeEF1A) in a vector derived fromCSII-EF-
MCS (15) (pEF1A derivatives, see Materials and Methods
and Supplementary Data). Similarly, we made expression
plasmids for eIF5 or its mutant carrying the Quad muta-
tion that abolishes eIF5 binding to eIF1 and eIF2 (14). The
expressed proteins have the N-terminal His6-tag and the C-
terminal triple FLAG-tag, allowing nickel-FLAG double
affinity purification of these proteins. Transfection of these
plasmids, along with the vector control, into HEK 293T
cells, displayed roughly equivalent expression of FLAG-
tagged proteins (Figure 1A, top two gels): Although 5MP1
expression tends to be lower than that of eIF5, eIF5-Quad
mutant expressed to the level equivalent to the wild-type
eIF5 (also see Figure 4A below). The expression of eIF5
and 5MP1 reduced protein synthesis, as measured by lu-
ciferase from a co-transfected constitutive reporter plas-
mid (Supplementary Figure S1). As a control, the treat-
Nucleic Acids Research, 2016, Vol. 44, No. 18 8707
Table 1. emPAI values for translation components associated with 5MP1 and eIF5 in complex II
Row Protein name Vector 5MP1 eIF5
1 FLAG-tagged protein 786 258
MFC components
2 eIF2 [, ,  ] 0.18 ± 0.08 94 ± 64# 45 ± 10#
3 eIF3 [a-m] 1.2 ± 0.2 7.0 ± 1.2* 1.4 ± 0.3
4 eIF1 (14 kDa) 0 4.0# 0
Other eIFs
5 eIF1A (16 kDa) 0 4.4# 1.9#
6 eIF2B [, ,  , , ] 0 5.4 ± 2.1# 1.8 ± 0.5*
7 eIF4G1 (176 kDa) 0.04 0.07 0.07
8 p97/NAT1/DAP5 (102 kDa) 0 1.1# 0.07#
9 eIF4B (70 kDa) 7.4 0.6 0.3
Ribosomal proteins
10 Small subunit proteins [30] 2.9 ± 0.5 6.9 ± 1.2* 2.0 ± 0.3
11 Large subunit proteins [36] 0.77 ± 0.23 1.7 ± 0.4* 1.3 ± 0.4
PRMT5:MET50 complex
12 PRMT5 (73 kDa) 26.2 0.05 0.1
13 MET50 (37 kDa) 6.78 0 0
The total emPAI values (17) for factor or ribosomal subunit indicated in column 1 are listed for vector-transfected, 5MP1 and eIF5 sample (columns 3–5).
For entries of a single polypeptide, their sizes are listed in parentheses (column 2). SEM is shown for data with multiple subunits. The names (eIFs) or
numbers (ribosomal subunits detected) of the subunits are shown in brackets. *, significant increases compared to the vector control sample (P < 0.05).
#, specificity inferred from the absence of the relevant protein(s) in the vector control sample. See Supplementary text for proteins mainly found in the
vector-transfected sample.
ment of vector-transfected cells with thapisgargin (Tg), a
known translational inhibitor drug, strongly reduced lu-
ciferase synthesis (Supplementary Figure S1, column 1).
The reduced luciferase synthesis confirms in human cells
that 5MP1 is a general translation inhibitor (5) and that
eIF5 overexpression turns eIF5 into an inhibitor of trans-
lation (4).
The double affinity purification of the FLAG/His6-
tagged proteins from HEK293T cell transfectants (see Ma-
terials and Methods for details) yielded purified samples of
the expressed proteins and co-purifying proteins (Complex
I in Figure 1A and B). eIF5 and 5MP1, but not eIF5-Quad
mutant, were co-purified with a 35-kDa protein, which was
identified as the  subunit of eIF2 byWestern blotting (with
anti-eIF2) (Figure 1C) and mass spectrometry (MS) (Sup-
plementary Table S1). MS also identified the  and  sub-
units of eIF2 as co-purifying proteins for both eIF5 and
5MP1 (Supplementary Table S1); eIF2 and eIF2 co-
migratedwith 5MP1 in the SDS-PAGE, and therefore could
not be identified in this complex by the Coomassie or sil-
ver staining (Figure 1A and B). As expected, the eIF5-Quad
mutation abolished eIF5 interaction with eIF2 (Figure 1A–
C). Thus, eIF5 and 5MP1 interact with eIF2 in human
cells at similar affinities, as expected from their similar in
vitro binding affinities to eIF2-NTT, the major substrate-
binding site (11,14).
Immunoblotting detected trace amounts of eIF3b sub-
unit in the eIF5 and 5MP1 complex I samples (Figure 1C,
lanes 6 and 8). To better study the interaction of eIF5 and
5MP1 with other translation factors than eIF2, we puri-
fied the complexes by omitting the nickel affinity purifica-
tion step, which may have inhibited interaction with them.
The single FLAG-affinity purification of both eIF5 and
5MP1 proteins yielded complexes containing, in addition
to the eIF2 subunits, proteins with sizes ranging from ∼170
to∼25 kDa (Complex II, Figure 1). These proteins are rem-
iniscent of eIF3 subunits and distinct from non-specific pro-
Figure 2. MS analysis of 5MP1 complex II. After SDS-PAGE and silver
staining, gels were sliced into12 pieces, each of which was subjected forMS
analysis. Table to the right summarizes emPAI values for proteins listed
across the top. On the bottom, sum of emPAI values is listed as total “mo-
lar” amount associated with 5MP1.
Figure 3. MS analysis of eIF5 complex II. emPAI values of detected pro-
teins are listed as in Figure 2.
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Figure 4. The effect of 5MP1 and eIF5 overexpression on ATF4 transla-
tional control in HEK293T and HT1080. (A) HEK293T cells are trans-
fected with 10:1:10 amounts of firefly luciferase plasmid (ATF4-luc [panel
1], uORF2-luc [panel 2] and ATF4-luc mutants altering start codon of
uORF2 [panel 3] or uORF1 [panel 4]), a Renilla luciferase plasmid and a
pEF1A derivative expressing indicated proteins or a vector control. After
2 days, cells were lysed to measure firefly and Renilla luciferase activities.
Graph indicates the firefly/Renilla luciferase expression ratio normalized
to the value for ATF4-luc vector control. For the experiment with ATF4-
luc, a portion of vector control transfectants was treated with 250 nM Tg
for overnight, and the luciferase activity was presented in dark grey. *, sig-
nificant changes compared to the value from vector control in each panel.
Panel 1, P = 0.017 (n = 10). Panel 2, P = 0.01, 0.001 (n = 8). Panel 3, P =
0.01, 0.02 (n = 6). Panel 4, P = 0.03 (n = 6). Hooked arrow, a significant
change (n = 8). (B) HT1080 cells are transfected similarly with ATF4-luc
plasmid and assayed for luciferase activities. * P < 0.02, compared to the
values from vector control in each panel (n = 4).
teins observed in the fraction from vector-transfected cells
(lane 1, Figure 1B). Immunoblotting indeed confirmed that
eIF3b is enriched in 5MP1 or eIF5 Complex II, compared
to the amount of eIF2. Thus, by omitting the nickel pu-
rification step, we were able to have more stable eIF3 asso-
ciation with eIF5 or 5MP1. Little or no eIF4E (a subunit of
eIF4F cap-binding complex) or ribosomal protein S6 was
found in all the samples tested (Figure 1C), in support of
specificity of complex II purification. TheWestern blot also
showed that eIF5 interaction with eIF3 depended on the in-
tact Quad residues important for eIF5 interactionwith eIF1
and eIF2 (14).
MS analysis of proteins associated with eIF5 and 5MP1
To elucidate the molecular composition of protein com-
plexes associated with eIF5 and 5MP1, we performed MS
on complexes II formed with these proteins (Figure 1C,
lanes 2 and 4; Supplementary Figure S2, lanes 2–3), along
with the fraction from vector transfected cells (Figure 1 and
Supplementary Figure S2, lanes 1). For each sample, the
whole lane was divided into 12 zones, each of which was
subjected toMS. As shown in Supplementary Table S2, ini-
tial assessment of the MASCOT output file (the summary
of the number of peptides observed per zone per protein
species) revealed that many proteins were specifically found
in complex II fractions of eIF5 and 5MP1 compared to pro-
teins found in the vector-transfected fraction. Strikingly, 12
of the 17 proteins most specifically associated with eIF5 and
5MP1 were initiation factors – all three subunits of eIF2,
a, b and c subunits of eIF3, all five subunits of eIF2B and
p97/NAT1/DAP5 (Supplementary Table S2).
Of proteins found in complex with eIF5 and 5MP1, lit-
tle or no peptides derived from eIF2 or eIF2B subunits or
p97/NAT1/DAP5 were found in the fraction from vector-
transfected cells, in support of the specificity of their associ-
ation (Supplementary Table S2). However, significant num-
bers of peptides derived from eIF3 subunits were found in
the vector-transfected fraction (Supplementary Table S2),
even though these numbers appeared to be lower than those
from eIF5 or 5MP1 complex II fractions. Because eIF3b
was not detected in the vector-transfected fraction for eIF5
or 5MP1 complex II in the immunoblot shown in Figure 1
(also see Figure 8), it appears that a small fraction of eIF3
bound to the FLAG affinity column in this particular ex-
periment (see Supplementary text for details).
Figures 2 and 3 summarize emPAI values for MFC com-
ponents found in the 12 zones of complex II fractions with
5MP1 and eIF5, respectively, as proxies for their molar
amounts. Most of the proteins listed here are found in the
zones expected from their sizes. The bottom of the graph
lists the sum of the proteins found in the whole lane, and
hence considered to be the estimated amount of associated
protein. Although total emPAI values for eIF2 and eIF3
subunits varied widely, they appeared to fall within the val-
ues expected for their presence in the same complex (eIF2
or eIF3) frompreviously determined correlation co-efficient
(17). We confirmed, however, that the ratios of average em-
PAI value for eIF2 to that of eIF5 or 5MP1 in respec-
tive complexes (1:8.6 and 1:5.6) matches well with the ra-
tio determined from Coomassie stained bands in Figure 1A
(on average, 1:14 and 1:7.9, respectively). Importantly, the
emPAI values for eIF3 subunit abundance in 5MP1 com-
plex were significantly higher than the values in the control-
treated sample (P < 0.001, n = 13; asterisk in Table 1, col-
umn 3). Because eIF1was also detected specifically in 5MP1
complex II fraction (Figure 2 and Table 1), we conclude that
5MP1 is able to form anMFC-like complex with eIF1, eIF2
and eIF3 in place of eIF5. Though MS did not provide ev-
idence for specific eIF5 binding to eIF3, all eIF3 subunits
were detected in the eIF5 complex II fraction (Figure 3).
Based on our western blot analysis in Figure 1C, we con-
clude that eIF5 forms a multifactor complex with eIF2 and
eIF3, as reported previously (8).
The semi-quantitative analysis also supports the assess-
ment that eIF5 and 5MP1 interact with eIF2B, the guanine
nucleotide exchange factor for eIF2 (Table 1, row 6). These
interactions might be bridged by eIF2, because the aver-
age emPAI values for the pentameric eIF2B complex were
several-fold lower than those for eIF2 in both the complex
II fractions (Table 1, rows 2 versus 6). Thus, the interac-
tion with eIF2B appears to depend on the amount of eIF2
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associated with eIF5 or 5MP1. A similar eIF5:eIF2:eIF2B
complex has been observed in yeast when eIF5 was overex-
pressed (4), and is suggested to play a role in controlling the
guanine nucleotide binding status of eIF2, with eIF5 serv-
ing as the guanine nucleotide dissociation inhibitor (GDI)
(9,19). Our results present the first evidence that 5MP1
makes a ternary complex with eIF2 and eIF2B, in agree-
ment with the model that 5MP1 can interact with GDP-
bound eIF2 (5). Other new interactions found in this study,
such as those with eIF1A (20) and p97/NAT1/DAP5 (Ta-
ble 1, rows 5, 8), are discussed in the Supplementary text.
Overexpression of 5MP1 and eIF5 promotes ATF4 expres-
sion in human cells
Having observed specific interaction of 5MP1 and eIF5
with eIF2 and eIF3, the major MFC components, we ex-
amined the model that 5MP1 and eIF5 overexpression in-
ducesATF4 translation through inhibition of initiation fac-
tor assembly. To test this, we transfected the ATF4-firefly
luciferease reporter plasmid with the paired uORFs (3),
along with the pEF1A-based overexpression plasmid and
a control Renilla luciferase plasmid. As shown in Figure
4A, panel 1, columns 3–4, we found that eIF5 overexression
induces ATF4 expression, dependent on its Quad residue.
However, the level of ATF4 induction was lower than the
level induced by a medium dose (250 nM) of thapisgargin
(Tg), the ER stress inducer that activates PERK eIF2 ki-
nase (Figure 4A, panel 1, column 1). 5MP1 overexpression
also did not significantly induce ATF4 in this experiment
(column 2).
In an effort to evaluate these findings, we performed as-
says using other reporter plasmids. The experiment with
a uORF2-luciferase plasmid showed that both eIF5 and
5MP1 expression inhibited the uORF2 translation (Fig-
ure 4, panel 2). Thus, the uORF2 start codon appears
to be bypassed not only by eIF5, as expected from in-
creased ATF4-luc activity (Figure 4A, panel 1), but also
by 5MP1. Provided that 5MP1 and eIF5 overexpression al-
lows a strong bypass of uORF2 translation, why did not
we observe strong ATF4-luc induction by these treatments?
To address this, we performed experiments with mutant
versions of the ATF4-luciferase plasmid, lacking the start
codon of uORF2 (uORF2; Figure 4, panel 3) or uORF1
(uORF1; Figure 4, panel 4). TheuORF2mutation elim-
inates the inhibitory effect of uORF2 and thereby confers
a high ATF4-luciferase activity (27-fold compared to WT
ATF4-luc) due to efficient re-initiation after uORF1 transla-
tion (Figure 4A, panel 3, column 1) (3). Importantly, 5MP1
or eIF5 overexpression suppressed the re-initiation atATF4
after uORF1 translation (Figure 4A, panel 3), perhaps ow-
ing to PIC dissociation from mRNA or even slower re-
acquisition of the eIF2 ternary complex (see the model in
Figure 4A, panel 3). Moreover, the experiment with the
uORF1 mutant confirms that uORF2 is translated nor-
mally in the presence of overproduced 5MP1 or eIF5, in-
hibitingATF4 translation (Figure 4A, panel 4: for the small
effect of eIF5 overexpression, see below). Therefore, the
overexpressed eIF5 and 5MP1 can cause the ribosomal by-
pass of uORF2 after uORF1 translation, but this event does
not appear to lead to strongATF4 re-initiation due to a sec-
ondary effect on PIC scanning. In regard to this point, the
experiment in Figure 4A, panel 4 also showed a minor but
significant increase inATF4 translation by eIF5 overexpres-
sion potentially through leaky scanning in the primary ini-
tiation event. This supports the idea that the secondary ef-
fect includes very slow TC reaquisition at least in the case
of eIF5 overexpression.
Encouraged by these findings, we examined three more
additional human cell lines, fibrosarcoma HT1080, HeLa
cells in which PKR is stably knocked down by sh RNA
(sh PKR), and its control expressing randomized RNA (sh
Control) and the insect cells Drosophila S2. We used the fi-
brosacorma cell lineHT1080, because the knockdown stud-
ies demonstrated that ATF4 is responsible for its tumor
growth in vitro and in vivo (21). The use of HeLa shPKR
(13) was prompted by our previous finding that 5MP1 over-
expression in mouse embryonic fibroblast eIF2α-S51A−/−
mutant induces ATF4 expression, but not in WTMEF (5).
Among the four human eIF2 kinases, we chose PKR for
knockdown, because PKRmay be activated during plasmid
transfection in response to transfection reagents or strong
RNA transcription from the transfected plasmid. The acti-
vated PKRmay in turn repress translation of FLAG-tagged
proteins from the transfected plasmids, thereby attenuating
the effect of 5MP1 or eIF5 on ATF4 induction.
As shown in Figures 4B and 5B panel 2, the overexpres-
sion of 5MP1 and eIF5 induced ATF4 expression in both
HT1080 and HeLa shPKR cells, as expected. Furthermore,
the effect of eIF5 depended on the Quad residues critical
for its interaction with eIF1 and eIF2 (columns 3 and 4).
In HeLa sh RNA control (shCtrl) cell lines, however, the
ATF4 induction by eIF5 was minor and smaller than that
by 5MP1 (Figure 5B, panel 1). Compared to the assay in
HeLa shCtrl, sh PKR treatment significantly increased the
magnitude of ATF4 induction by eIF5 overexpression (P<
0.001, n = 9; compare columns 3 in Figure 5B). The over-
all weaker effect of eIF5 and 5MP1 in shCtrl cells is appar-
ently due to their lower expression levels compared to those
in shPKR cells (Figure 5A), in agreement with the ratio-
nale as described above. We found that the ATF4-luc level
is higher in shCtrl than in shPKR line (Figure 5C), suggest-
ing that PKR is activated through transfection under the
experimental conditions.
Paired uORFs suited for induction by eIF2 inhibition
are found in the leader regions of all the ATF4 mRNAs in
Metaoza (except for nematodes). Though the 5MP knock-
down decreased the transcription of an ATF4-dependent
gene in the red flour beetle, Tribolium castaneum (11), a di-
rect effect of 5MP on ATF4 expression has not be exam-
ined in insects. To test this, we generated ATF4-luc reporter
using ATF4 mRNA from D. melanogaster (Dme). Control
transfection with a luciferase plasmid indicates that expres-
sion of 5MP fromD.melanogaster orT. castaneum (Tca, red
flour beetle) strongly attenuates luciferase protein synthesis
(Figure 6A and B). Conversely, experiments with the Dme
ATF4-luc plasmid show that Dme and Tca 5MP expression
induces ATF4 expression (Figure 6C and Supplementary
Figure S3). Thus, 5MP is a translational inhibitor and spe-
cific inducer of ATF4 in insects as well.
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Figure 5. The effect of 5MP1 and eIF5 overexpression on ATF4 transla-
tional control in HeLa cells knocked down for PKR eIF2K. HeLa cells
knocked down for PKR (shPKR, panel 1) or expressing a randominzed
sh RNA (shCntrl, panel 2) are transfected with the ATF4-luc plasmid,
the Renilla lucifereae plasmid and pEF1A derivatives, as in Figure 4A,
panel 1, and assayed for ATF4-luciferease activity. (A) Immunoblot analy-
sis of lysates fromHeLa transfectants with indicated treatments. Top, anti-
FLAG. Bottom, anti-actin. (B) Graph indicates ATF4-luc/Renilla luc ex-
pression ratio under expression of indicated proteins, relative to the value
from vector control. *P < 0.05 compared to value with the vector control
in each panel. Panel 1, P = 0.007 (n = 10). Panel 2, P = 0.07, P < 0.0001
(n = 10). **P= 0.05 (n = 10). Hooked arrow, a significant change (n = 7).
(C) ATF4-luc/Renilla luc expression ratio was compared between vector-
control experiments for HeLa shCtrl and shPKR lines that are done in
parallel.
5MP1 promotes fibrosarcoma tumorigenesis
The finding that 5MP1 stimulates ATF4 expression in
HT1080 promoted us to examine the role of 5MP1 in fi-
brosarcoma tumorigenesis (21). If the ATF4 expression at
least partially depends on 5MP1, the 5MP1 knockdown is
expected to compromise its tumorigenicity. We generated
a stable HT1080 cell line knocked down for 5MP1 by an
sh5MP1 plasmid, in which the level of 5MP1 was decreased
by 45% (Figure 7A). As a control, we generated a stable
transfectant of HT1080 expressing sh GFP RNA (shGFP).
The resulting sh5MP1 clone termed 5.3 displayed reduced
cell growth in vitro, compared to naı¨veHT1080 andHT1080
shGFP (Figure 7B) and a modest reduction in ATF4-luc
expression, as examined with the ATF4-luc plasmid (Fig-
ure 7C). The magnitude of ATF4 induction by Tg was not
altered by sh5MP1, however (Figure 7C). These results in-
Figure 6. The effect of 5MP expression on translational control in insect
cells. (A andB)Drosophila S2 cells were transfected with 5:1:25 amounts of
pAc5.1C-Fluc-V5His6, pAc5.1C-Rluc-V5His6 and pAc-Dme5MP, pAc-
Tca5MP or vector control (see Supplementary file for details). Expressed
5MP proteins are tagged with FLAG-epitope at their C-termini. After 2,
3 and 5 days, a portion of the cells are withdrawn for Western blotting
with anti-FLAG and anti-actin (A) or dual firefly and Renilla luciferase
assays. (A) Immunoblots with cells on day 3. Graph in (B) shows the fire-
fly luciferase expression relative to the vector control for each experiment.
Expression ratio of firefly and Renilla luciferase was unaltered by 5MP ex-
pression (Supplementary Figure S3). (C) Transfection of S2 cells was done
as in (A) and (B) except with p1696 with DmeATF4 leader region cloned
between the actin promoter and luciferase coding region of pAc5.1C-Fluc-
V5His6, in place of the Fluc plasmid. Transfected cells were analyzed as in
(A) and (B). Graph indicates the firefly/Renilla expression ratio for trans-
fectants expressing indicated proteins, relative to the vector control on day
2 and 3. *, significant changes compared to the vector control. Days 2–
3, P = 0.01, 0.04 (n = 7). Day 5, P = 0.003, 0.02 (n = 4). Schematic on
top shows the structure of Dme ATF4 leader region. Immunoblot on the
bottom shows experiment with p1696 transfectants on day 3, conducted in
parallel with experiment in (A).
dicate that 5MP1 knockdown reduces ATF4 expression in
and in vitro growth of HT1080.
To verify the reduced expression of endogenous ATF4,
we performed immunocytochemistry with anti-ATF4. As
shown in Figure 7D, we observed predominant nuclear lo-
calization of ATF4 in naı¨ve HT1080 (Figure 7D), and the
anti-ATF4 signal was somewhat reduced in the clone 5.3
cells (Figure 7D). As shown in Figure 7E, our quantifica-
tion showed that the anti-ATF4 signal per cell was reduced
significantly to 78%, in agreement with reduced ATF4-luc
transgene expression.
To examine the effect of sh5MP1 on tumor growth in
vivo, we inoculated the clone 5.3 cells (2 × 106) into one
hind flank of five nude mice. As controls, we inoculated the
same number of naı¨ve HT1080 into the opposite flank of
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Figure 7. Fibrosarcoma HT1080 cells knocked down for 5MP1 display
decreased ATF4 expression and tumorigenicity. Stable HT1080 transfec-
tants expressing shRNA against 5MP1 (clone 5.3) and GFP (as a control)
were generated and assayed as described inMaterial andMethods. (A) Im-
munoblot of lysates prepared from clone 5.3 (sh 5MP1) or sh GFP con-
trol. Equal protein amounts were loaded and treated with antibodies in-
dicated to the left. (B) Cell titor assay was performed with naı¨ve HT1080,
clone 5.3 and shGFP control and presented in a graph. (C) Clone 5.3 and
shGFP control lines were transfected with 10:1 amounts of the ATF4-luc
and Renilla luciferase plasmids. On day 1, a portion of the cells was treated
overnight with Tg (250 nM). On day 2, firefly and Renilla activities were
assayed. Firefly:Renilla expression ratio was presented relative to the value
with untreated shGFP cells. (D and E) Clone 5.3 and naı¨ve HT1080 cells
were stained with DAPI (blue) and anti-ATF4 (red). Isotype, mouse IgG
was used for HT1080 as control. (E) Integral density of anti-ATF4 sig-
nal was quantified for 25 clone 5.3 and 30 HT1080 cells and presented. See
SupplementaryMethod for details. (F andG) Clone 5.3 and naı¨ve HT1080
cells were inoculated to left and right rear flanks of five nude mice. Left
graph indicates the weight of tumors generated by these cells and collected
after indicated times. Right graph shows the analysis of relative size of the
tumors. (G) Isolated tumors (left) and hematoxilyn and eosin staining of
the tumor sections (right). Arrows indicate dividing cells. Bar, 100 m.
the same five mice. As shown in Figure 7F, the weight of
tumors derived from clone 5.3 was smaller than that of tu-
mors derived from naı¨ve HT1080 in four nude mice and, on
the fifth mouse, no tumor was observed with clone 5.3 cells.
Overall, sh5MP1 reduced the tumor size to 21% of the par-
ent tumor, HT1080 (P < 0.001, n = 5). Pathological anal-
ysis of tumors isolated from nude mice confirmed that the
tumor was fibrosarcoma and that the tumors derived from
clone 5.3 contained smaller and fewer dividing cells (Fig-
ure 7G). These results indicate that 5MP1 contributes to
fibrosarcoma tumorigenicity. Given the significant but mi-
nor effect on ATF4 expression, we suggest that ATF4 is at
least one of the many targets of 5MP1. We propose that
5MP1 promotes tumorigenecity through controlling mul-
tiple genes with uORFs, including ATF4, in their mRNA
leader regions (see Discussion).
5MP2 (BZW1) interacts with eIF2 and eIF3 and induces
ATF4 expression in human cells
5MP2 is overexpressed in certain types of cancers, and
5MP2 knockdown in salivary mucoepidermoid carcinoma
(MEC) reduces its tumorigenicity, implicating 5MP in tu-
Figure 8. 5MP2/BZW1 reported to be overproduced in certain tumors
binds eIF2 and eIF3 and induces ATF4 expression in HEK293T. (A and
B) Single FLAG affinity purified complexes of 5MP1 and 5MP2 (Com-
plex II) are analyzed by (A) silver staining and immunoblotting as in Fig-
ure 1. (C) ITC assay. Human eIF253-136 carrying two K-boxes (161.5
M), which are the major determinants of interaction with eIF5 (30),
was injected into the human 5MP2 sample (20 M). The ITC experiment
was performed as described previously (11,14). (D) ATF4- or uORF2-
luciferase activities from cells transfected with the indicated reporter plas-
mid and pEF1A-h5MP2 are measured and presented as in Figure 4A.
*, significant changes compared to the value from vector control in each
panel. Panel 1, P = 0.03 (n = 6). Panel 2, P = 0.01 (n = 6).
morigenesis (6). However, the molecular target of 5MP2
in tumorigenesis has not been identified. In order to test
if 5MP2 overexpression can induce ATF4, we generated a
pEF1A derivative encoding human 5MP2 and performed
the interaction assay by purifying 5MP2 complex II and the
ATF4-luc reporter assay. As shown in Figure 8A and B, the
5MP2 complex II specifically contained eIF2 and eIF3b
(lane 2) as found in the 5MP1 complex II (lane 3). Direct
5MP2 binding to eIF2 was confirmed by isothermal titra-
tion calorimetry (ITC), demonstrating a tight binding affin-
ity of KD = 1.5 M, comparable to the reported affinity for
5MP1 or eIF5 binding to the same protein (11,14) (Figure
8C).
We found that the 5MP2 overexpression induced ATF4
expression by 3-fold in HEK293T (Figure 8D, panel 1).
The 5MP2 overexpression reduced protein synthesis simi-
lar to 5MP1 (Supplementary Figure S1, column 4), strongly
decreased uORF2 translation (Figure 8D, panel 2), indi-
cating uORF2 bypass, but did not decrease the expression
8712 Nucleic Acids Research, 2016, Vol. 44, No. 18
from ATF4 uORF2 reporter (Figure 8D, panel 3). This
last finding suggests that 5MP2 overexpression does not
caused the secondary effect on PIC scanning, which other-
wise would compromise the ability of overproduced 5MP2
to induce ATF4, as observed with 5MP1 in HEK293T cells
(Figure 4A). These results support the notion that 5MP
overexpression in general leads to translational induction
of ATF4 in metazoa including both normal and cancerous
human cells.
DISCUSSION
The essential roles eIF5 plays in promoting the PIC assem-
bly and accurate translation initiation have been established
well in yeast (22,23). However, the role of eIF5 in human bi-
ology is underexplored, in particular, in the context of the
PIC assembly and regulation, as well as the biological con-
sequence of its overproduction. In this paper, we found for
the first time that, similar to yeast, eIF5 overexpression in
human cells turns eIF5 into a translation inhibitor (Sup-
plementary Figure S1), thereby inducing ATF4 translation
(Figures 4A, B and 5B). This effect is brought about by the
strong ability of eIF5 to bind eIF2, whichwas demonstrated
by our affinity-purification studies (Figure 1). As shown in
yeast previously, the overproduced eIF5 not only bound ad-
ditionally to eIF3 (Figures 1, 3 and Table 1), in support of
MFC formation in mammalian cells (8), but also to eIF2B
(Table 1), in support of its binding to GDP-bound eIF2
(4,24).
Our finding that 5MP1 binds eIF2 in human cells almost
as strongly as eIF2 binds eIF5 (Figure 1) agrees with the
previous findings that 5MP1 and eIF5 bind eIF2-NTT at
a similar affinity (11) and thereby compete for eIF2 (5). Our
affinity purification study also revealed 5MP1 interaction
with eIF1, eIF3 and eIF2B, similar to the results with eIF5-
purification studies (Figure 1 and Table 1). It is conceivable
that these proteins associate with the 5MP1:eIF2 complex
as the core; eIF1 and eIF3 bound through eIF2:GTP:Met-
tRNAiMet TC in a MFC-like complex, and eIF2B bound
through eIF2:GDP. Like the eIF5-mediated complexes, for-
mation of these complexes is likely to reduce the TC recruit-
ment and abundance, thereby inducing ATF4 translation
(Figures 4B and 5A and B).
Compared to eIF2 phosphorylation, the ability of over-
produced eIF5 or 5MP to induce ATF4 was weak. This is
partly because the overproduced proteins appear to cause
a secondary effect through attenuating the PIC scanning in
the ATF4 mRNA leader (Figure 4A, panels 2 and 3). In
agreement with this idea, eIF5 overexpression is known to
destabilize the scanning competent form of the PIC in yeast
and human, thereby allowingmis-initiation from non-AUG
codons (25,26). The inhibitory effect of 5MP1 on the scan-
ning PIC is consistent with its binding to eIF3, the ribosome
binding factor (5) (Figures 1 and 2), and the fact that 5MP
does not possess the GAP function carried by eIF5. Alter-
natively, the weak effect of eIF5 or 5MP might be due to
competition with eIF2B, which can vary depending on the
intensity of eIF2K signaling by an unknown mechanism.
Overexpression of initiation factors, such as eIF4E
and eIF3 subunits, and a concomitant increase in cap-
dependent mRNA translation have been associated with tu-
morigenesis (27). In the case of eIF5 and 5MP, their overex-
pression decreases general translation, but it can contribute
to tumorigenesis through enhancing ATF4 expression in fa-
vor of tumor survival during stress conditions (hypoxia and
nutritional deprivation) encountered by cancer cells in their
development and metastasis (28). Our 5MP1-knockdown
studies on fibrosarcoma (Figure 7) supports this hypothesis.
In regard to the role of 5MP and eIF5 in tumorigenesis, the
following questions remain unanswered: Precisely how do
these proteins promoteATF4 translation? How is the inten-
sity of ATF4 induction regulated in different cell types and
conditions? Is overexpression necessary for 5MPs to pro-
mote tumorigenesis? Finally, is ATF4 the sole target of this
regulation? For the 5MP expression levels in cancer, while
5MP2 (BZW1) was overexpressed in salivary mucoepider-
moid carcinoma, the level of 5MP1 or 5MP2was equivalent
to eIF2 level in the breast carcinoma cell line MCF7 (12).
We also confirmed that the levels of 5MP1 and 5MP2 in fi-
brosarcomaHT1080 are similar to those in HEK293T (HH
and KA, personal observations). Furthermore, consistent
with 5MP1-knockdown studies in fibrosarcoma, we showed
previously that RNAi-mediated knockdown of 5MP in the
red flour beetle (the sole copy in the organism) attenuates
transcription from a ATF4-dependent gene (11). Therefore,
the expression of 5MP at its normal level (not necessarily its
overexpression) may contribute to a basal-level ATF4 ex-
pression. We also do not know the significance of tissue-
specific expression patterns of 5MP1 and 5MP2 from tran-
scriptomics studies (11). As for the number of potential
5MP targets, the recent ribosome profiling study showed
that eIF2 inhibition leads to up-regulation of translation of
a subset of genes with uORFs in their mRNA leader re-
gion (29). These genes include ATF4, ATF5 (the paralog of
ATF4), and the eIF2 phosphatase GADD34 and are po-
tentially regulated by 5MP. More works regarding the role
of eIF5 and 5MP in cancer biology will add new insights
into the development of cancer therapies through transla-
tional control.
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